| Literature DB >> 29980172 |
Sean G Young1, Andrew Kitchen2, Ghazi Kayali3,4, Margaret Carrel5,6.
Abstract
BACKGROUND: Avian influenza H5N1 has a high human case fatality rate, but is not yet well-adapted to human hosts. Amino acid substitutions currently circulating in avian populations may enhance viral fitness in, and thus viral adaptation to, human hosts. Substitutions which could increase the risk of a human pandemic (through changes to host specificity, virulence, replication ability, transmissibility, or drug susceptibility) are termed key substitutions (KS). Egypt represents the epicenter of human H5N1 infections, with more confirmed cases than any other country. To date, however, there have not been any spatial analyses of KS in Egypt.Entities:
Keywords: Avian influenza; Egypt; Landscape genetics; Poultry
Mesh:
Substances:
Year: 2018 PMID: 29980172 PMCID: PMC6035396 DOI: 10.1186/s12879-018-3222-6
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Detected KS in Egypt with phenotypic consequences and references, adapted from CDC’s Inventory
| Protein | Amino Acid Change(s) | Detections in Egypt | Previously Reported in Egypt | Phenotypic Consequences |
|---|---|---|---|---|
| HA | D94N | 738 | Yes | Increased viral binding to alpha,2–6; enhanced virus fusion [ |
| S133A | 40 | Yes | Increased pseudovirus binding to alpha,2–6 [ | |
| A134V | 1 | Yes | Increased infectivity in SIAT Cells [ | |
| G139R | 7 | No | Increased virus binding to alpha,2–6 [ | |
| S155N | 470 | Yes | Increased virus binding to alpha,2–6 [ | |
| T156A | 656 | Yes | Increased virus binding to alpha,2–6 and increased transmission in guinea pigs [ | |
| N182K | 3 | Yes | Increased virus binding to alpha,2–6 [ | |
| E186G | 1 | No | Increased virus binding to alpha,2–6 [ | |
| T188I | 17 | Yes | Increased pseudovirus binding to alpha,2–6 [ | |
| K189R | 722 | Yes | Increased virus binding to alpha,2–6 [ | |
| Q192R/H | 11 | Yes | Increased virus binding to alpha,2–6 [ | |
| N193K | 1 | No | Increased virus binding to alpha,2–6 [ | |
| V210I | 12 | Yes | Increased virus binding to alpha,2–6 [ | |
| S223N | 6 | Yes | Increased virus binding to alpha,2–6 [ | |
| P235S | 733 | Yes | Increased virus binding to alpha,2–6 [ | |
| E75K, S123P | 1 | No | Increased virus binding to alpha,2–6 [ | |
| L129-, I151T | 453 | Yes | Increased virus binding to alpha,2–6 [ | |
| S133A, T188I | 1 | No | Increased pseudovirus binding to alpha,2–6 [ | |
| S155N, T156A | 359 | Yes | Increased virus binding to alpha,2–6 [ | |
| S155N, T156A, S223N | 3 | No | Increased virus binding to alpha,2–6; reduced lethality and systemic spread in mice [ | |
| T156A, S223N | 6 | No | Increased virus binding to alpha,2–6 [ | |
| M1 | N30D | 99 | Yes | Increased virulence in mice [ |
| T215A | 100 | No | Increased virulence in mice [ | |
| M2 | V27A | 1 | No | Reduced susceptibility to amantadine and rimantadine [ |
| S31N/G | 53 | Yes | Reduced susceptibility to amantadine and rimantadine [ | |
| NA | 49–68 deletion | 366 | Yes | Enhanced virulence in mice [ |
| I97V | 1 | No | Reduced susceptibility to oseltamivir [ | |
| I203M/V/L/K/R | 1 | No | Reduced susceptibility to oseltamivir [ | |
| H254Y/R | 379 | No | Reduced susceptibility to oseltamivir and peramivir [ | |
| N275S | 4 | Yes | Reduced susceptibility to oseltamivir [ | |
| NS1 | P42S | 118 | Yes | Increased virulence in mice [ |
| 80–84 deletion | 128 | Yes | Increased virulence in mice [ | |
| L98F | 111 | No | Increased virulence in mice [ | |
| I101M | 118 | No | Increased virulence in mice [ | |
| NS1 & NS2 | N200S (NS1), T47A (NS2) | 38 | No | Decreased antiviral response in host [ |
| PB1-F2 | N66S | 1 | Yes | Increased virulence, replication efficiency, and antivirus response in mice [ |
| PB2 | E627K | 94 | Yes | Increased replication efficiency in cell culture and enhanced virulence in mice; enhanced polymerase activity and mammalian host adaptation; transmissible among ferrets [ |
| D701N | 1 | No | Enhanced replication efficiency, increased virulence and transmission in guinea pigs; mammalian host adaptation; increased virulence in mice [ | |
| L89V, G309D, T339L, R477G, I495V, L627E, A676T | 1 | No | Enhanced polymerase activity and increased virulence in mice [ |
Fig. 1Locations for which spatial clusters of high KS detection rates were evaluated. Governorate centroids and boundaries shown, with dasymetrically-adjusted populated places shown with hatching
Fig. 2Counts of viral samples that met inclusion criteria by governorate
Summary of KS detections by viral protein
| Protein | # of KS | # of Samples with KS Detected/Total Samples (%) |
|---|---|---|
| HA | 21 | 789/825 (95.6) |
| M1 | 2 | 100/112 (89.3) |
| M2 | 2 | 54/103 (52.4) |
| NA | 5 | 381/381 (100) |
| NS1 | 4 | 130/130 (100) |
| NS2 | 1 | 38/108 (35.2) |
| PB1-F2 | 1 | 1/88 (1.1) |
| PB2 | 3 | 94/116 (81) |
| Totala | 39 | 874/925 (94.5) |
aMany samples included multiple protein sequences, so the total number of samples is smaller than the sum of the individual protein sequences would suggest
Fig. 3Temporal distribution of viral samples and KS detection rates by year
Summary of detected KS by phenotypic consequences groups (PCG)
| Phenotypic Consequences Group (PCG) | KS in PCG | Samples w/ KS Detected | Mean Detection Rate |
|---|---|---|---|
| PCG1: Host Specificity | 23 | 800/836 | 0.26 |
| PCG2: Virulence | 13 | 851/918 | 0.58 |
| PCG3: Replication | 5 | 98/846 | 0.08 |
| PCG4: Transmissibility | 3 | 704/836 | 0.71 |
| PCG5: Antiviral Susceptibility | 8 | 400/446 | 0.25 |
Fig. 4Summary of hot spot analyses for overall KS detection rates. The governorates of Alexandria and Beheira were the only locations identified as containing probable hot spots using both dasymetric adjustment (> 9500 iterations) and governorate centroids
Fig. 5Summary of hot spot analyses for KS detection rates by PCG, using (a) dasymetrically-adjusted sample locations (> 9500 iterations), and (b) governorate centroids
Results of hot spots analyses for overall KS detection rates and by PCG
| Governorate | Overall KS | PCG1 | PCG2 | PCG3 | PCG4 | PCG5 |
|---|---|---|---|---|---|---|
| Alexandria | 10000a | 9927 | 9187a | 17 | 35 | 2055 |
| Aswan | 0 | 115 | 0 | 0 | 132 | 0 |
| Asyut | 0 | 1 | 0 | 0 | 7891a | 0 |
| Beheira | 10000a | 9909 | 9778a | 1483 | 2025 | 5304 |
| Beni Suef | 0 | 4533a | 1 | 3 | 2918 | 0 |
| Cairo | 4 | 0 | 10 | 0 | 1 | 0 |
| Dakahlia | 2 | 677a | 103 | 51 | 658 | 9 |
| Damietta | 0 | 9 | 1 | 26 | 24 | 0 |
| Faiyum | 2 | 5405a | 0 | 632 | 8490a | 3 |
| Gharbia | 6955 | 4843 | 3649 | 422 | 1971 | 3092 |
| Giza | 143 | 217 | 133 | 52 | 477 | 0 |
| Ismailia | 0 | 0 | 0 | 0 | 1 | 1 |
| Kafr El Sheikh | 6649 | 5308 | 3333 | 920 | 1700 | 2143 |
| Luxor | 0 | 83 | 0 | 0 | 471 | 0 |
| Matruh | 326 | 184 | 62 | 0 | 0 | 49 |
| Minya | 0 | 124 | 0 | 0 | 1214 | 0 |
| Monufia | 2460 | 942 | 1484 | 557 | 1738a | 310 |
| New Valley | 0 | 6 | 0 | 0 | 200 | 0 |
| North Sinai | – | – | – | – | – | – |
| Port Said | 0 | 0 | 0 | 22 | 0 | 5 |
| Qalyubia | 0 | 0 | 2 | 0 | 0 | 0 |
| Qena | 0 | 111 | 0 | 0 | 357 | 0 |
| Red Sea | – | – | – | – | – | – |
| Sharqia | 0 | 0 | 0 | 16 | 7 | 0 |
| Sohag | 0 | 1467 | 0 | 0 | 1692 | 0 |
| South Sinai | – | – | – | – | – | – |
| Suez | 0 | 1 | 0 | 0 | 3 | 0 |
The number of iterations (out of 10,000) in which statistically significant hot spots were detected using dasymetric adjustment is shown for each governorate, while an aindicates hot spots detected in a single run using governorate centroids